๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Inhibition of human endometrial cancer cell growth in vitro and in vivo by somatostatin analog RC-160

โœ Scribed by Misako Mishima; Tetsu Yano; Haruko Jimbo; Naomi Yano; Yutaka Morita; Hiroyuki Yoshikawa; Andrew V. Schally; Yuji Taketani

Book ID
113986444
Publisher
Elsevier Science
Year
1999
Tongue
English
Weight
102 KB
Volume
181
Category
Article
ISSN
1097-6868

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Somatostatin analog RC-160 inhibits the
Somatostatin analog RC-160 inhibits the growth of human osteosarcomas in nude mice
โœ Jacek Pinski; Andrew V. Schally; Gabor Halmos; Karoly Szepeshazi; Kate Groot ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 627 KB

We investigated the effects of the potent somatostatin analog RC-160 on the growth of human osteosarcoma cell lines SK-ES-I and MNNG/HOS, transplanted into nude mice or cultured in vitro. Growth of SK-ES-I and MNNG/HOS tumors in nude mice was significantly inhibited after 4 weeks of treatment with d

Somatostatin analog RC-160 inhibits grow
Somatostatin analog RC-160 inhibits growth of CFPAC-1 human pancreatic cancer cells in vitro and intracellular production of cyclic adenosine monophosphate
โœ Yunfcng Qin; Tibor Ertl; Kate Groot; Judit Horvath; Ren-Zhi Cai; Andrew V. Schal ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 832 KB

The effect of somatostatin analog RC-I60 on the growth of CFPAC-I human pancreatic cancer cells in vitro was investigated. RC-I60 effectively inhibited the proliferation of CFPAC-I cells in culture, inducing a time-and dose-dependent decrease in the number of treated cells. A significant suppression

Inhibition of the growth of caki-I human
Inhibition of the growth of caki-I human renal adenocarcinoma in Vivo by luteinizing hormone-releasing hormone antagonist cetrorelix, somatostatin analog RC-160, and bombesin antagonist RC-3940-II
โœ Andreas Jungwirth; Andrew V. Schally; Gabor Halmos; Kate Groot; Karoly Szepeshaz ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 224 KB ๐Ÿ‘ 2 views

## Background: Metastatic or recurrent renal cell carcinoma (rcc) is a therapeutic challenge because it is resistant to chemotherapy and external radiotherapy. no uniformly effective therapeutic agents are available for the management of patients with rcc. hormones and growth factors may play a rol